Last Week in Longevity #8 - $121M raised + Biostasis goes (more) mainstream
Your weekly business digest of everything that happened in longevity.
đ Hi, I am Fabian, and welcome to my newsletter Last Week in Longevity. Every week, I track where the money, talent, and ideas are moving in the longevity business.
đ¸ Closed funding rounds
US$ 121M raised across 4 deals (âď¸ -88% vs. US$ 1,002M across 6 deals last week)
Until Labs â US$ 58M (Series A) | San Francisco, USA
What they do: Developing organ cryopreservation technology for transplantation, pausing biological time to extend the viable window for donated organs.
Why it matters: Extending organ viability not only saves transplant patients but also lays the groundwork for broader biostasis applications.
Investors: Led by Founders Fund, with Lux and Field Ventures joining in
Valuation: unknown
Sunrise Group (Dreem Health) â US$ 29M (Series A) | Paris, France & New York, USA
What they do: Expanding Dreem Health, a network of sleep clinics augmented by digital sleep tracking, to become the largest US provider of sleep diagnostics and therapy.
Why it matters: Poor sleep accelerates nearly every hallmark of aging (inflammation, mitochondrial dysfunction etc.). Scaling modern sleep clinics puts one of the most powerful levers of healthspan into mainstream care.
Investors: Led by Eurazeo, with participation from Amazonâs Alexa Fund, WE International, Kurma Partners, Vives Fund, Majycc and others
Valuation: unknown
Manas AI â US$ 26M (Seed Extension) | New York, USA
What they do: Building a generalist biomedical AI agent that integrates omics, imaging, and literature to propose new drug targets and therapeutic hypotheses.
Why it matters: Longevity medicine is multi-modal and complex; an AI engine able to synthesise biology at scale could accelerate target discovery for hallmarks like senescence, mitochondrial dysfunction, or proteostasis loss.
Investors: The General Partnership, Wisdom Ventures, Blitzscaling Ventures, Westbound Equity Partners, Mosaic Ventures
Valuation: unknown
FYR Bio â US$ 8M (Seed/early funding) | Missoula, USA
What they do: Using advanced neuroproteomics and biomarker discovery to identify early warning signals for Parkinsonâs disease and expand to other neurodegenerative conditions.
Why it matters: Neurodegeneration is one of the largest barriers to healthy aging. Earlier, blood-based biomarkers could enable pre-symptomatic intervention, shifting from late-stage management to prevention.
Investors: The Sonntag Innovation Fund and Yuvaan Tiwari Foundation
Valuation: unknown
đ° Top longevity business news
GLP-1 + X = IP moats & better outcomes?
What happened: Austin-based MindWalk announced an AI-designed GLP-1 analog paired with a companion therapeutic acting via a complementary âhealthy-agingâ pathway, framing a dual-pathway regimen for healthspan. Read more here.
Why it matters: We have seen Eli Lilly and Novo Nordisk framing GLP-1s as the first longevity drug. MindWalk is going down the same path, saying that biomarkers of aging and healthspan endpoints are being incorporated into the preclinical prioritisation process. Also, combo regimens could create IP moats and better outcomes, positioning MindWalk in the high-margin âGLP-1 + Xâ stack many pharma players are chasing.
L-Nutra Ă Parsley Health partnership
What happened: L-Nutra partnered with Parsley Health to embed fasting-mimicking protocols and products into Parsleyâs physician-led metabolic programs, training care teams and selling via its store. Read more here.
Why it matters: This shifts longevity nutrition from DTC into clinical workflows, improving adherence, medical legitimacy, and unit economics through platform distribution.
đ Events & meetups (Europe-only)
(UK) Healf Experience (Oct 3-5, 2025)
(CH) Biostasis 2025 (Oct 10-12, 2025)
(LU) Longevity & Biohacking Retreat (Oct-Nov 24-04, 2025)
(CH) Global Longevity Summit (Oct 28-30, 2025)
(FR) Tech for Longevity 2025 (Nov 25-26, 2025)
(ES) 4th Longevity World Forum (Feb 18-20, 2026)
(CH) SIP Longevity Retreat (Apr 20-24, 2026)
(PT) 4th Global Longevity Med Summit (May 6-7, 2026)
(DE) LIFE Summit (May 29-30, 2026)
(IE) Longevity Summit Dublin (Jun 24-26, 2026)
(NL) HLTH Europe (Jun 15-18, 2026)
(CZ) 8th World Aging & Rejuvenation Conference (Jun 18-19, 2026)
(AT) 2nd World Congress on Future of Aging & Rejuvenation Science (Jul 20-21, 2026)
(DE) POLLY Longevity Festival (Aug 21-23, 2026)
đź Longevity jobs (Europe-only)
Germany:
(Berlin) CRM Manager @ Aware
(Berlin) Expansion Manager @ Circle Health
(Berlin) Automation Associate @ Circle Health
(Berlin) Co-Founder / CXO @ Life Summit
(Berlin) Product Development Manager Longevity @ Sunday Naturals
(Berlin) Founder Associate @ Kalia Lab
(Berlin) Working Student Data Science @ YEARS
(KĂśln) Postdoctoral Research Fellow @ Max Planck Institute for Biology of Aging
(MĂźnchen) Medical Director @ Circle Health
(MĂźnchen) Heilpraktiker @ Longevity Mitosphere Spa
(Dßsseldorf) Ernährungscoach @ Intumind
(Karlsruhe) Medizinische Fachangestellte fĂźr Longevity-Medizin @ belleaesthetics
Rest of Europe:
(London/remote) Head of Legal @ Healf
(London/remote) Founderâs Associate @ Healf
(London) Product Manager @ Juniper UK
Keep building the future of longevity - one week at a time.
Fabian
P.S. Want your open positions or events to be featured? Just send them my way by replying to this email.